Global Radiopharmaceuticals Market Gaining from Rising Prevalence of Chronic Diseases
Radiopharmaceuticals refer to a group of pharmaceutical drugs that exhibit radioactivity, and are used as therapeutic and diagnostic agents as they evoke no physiological response from the patients. These drugs are primarily based on physiological properties of the targeted organs. Owing to increased incidences of cancer and cardiovascular diseases, growing awareness pertaining to the availability of radiopharmaceutical drugs, and preference for SPECT and PET scans are some of the factors that are driving the expansion of the global radiopharmaceuticals market. Moreover,...
View full press release